ERBB2 and breast neoplasm: We used the differentially expressed genes to perform pathway analysis with Reactome and found that ERBB2 signaling, integrin cell-surface interactions and various metabolic processes were reduced in luminal-like breast tumors whereas interferon signaling, expression of glycoprotein tumor antigens termed T and Tn, and mitotic rates were increased in these same tumors.